All In MedTech

Device Trial Radar · NCT04249492

PMCF Study on EDOF (Isopure) vs Monofocal (Micropure) IOL

Multicentric Post-Market Clinical Follow-up (PMCF) Investigation to Determine Safety and Efficacy of a Hydrophobic EDOF Intraocular Lens (IOL) in Comparison to a Monofocal IOL

Last checked: Nov 20, 2026Latest source record: Nov 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 250 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

250

Actual

Start

Feb 11, 2020

Primary completion

Feb 23, 2023

Study completion Apr 18, 2024

Sponsor

Lead sponsor
Beaver-Visitec International, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
targomedGmbH
First posted
Jan 31, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Multicenter, prospective, randomised, controlled, single-blind post-market clinical follow-up (PMCF) study to compare the clinical outcomes of an enhanced depth of focus (EDOF) IOL with the outcomes obtained with a monofocal lens. Implantation of the IOLs is bilaterally.

Conditions

  • Cataract
  • Lens Opacities

Interventions

  • IOL implantation experimental (Isopure 1.2.3.)Device

    Implantation of trifocal IOL POD F GF consisting of light distribution order: far \> intermediate \> near

  • IOL implantation active comparator (Micropure 1.2.3.)Device

    Implantation of trifocal IOL POD F GF consisting of light distribution order: far \> near \> intermediate

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. monocular Best Corrected Distance Visual Acuity (CDVA) under photopic light conditions on the first implanted eye.Time frame: 6 months (120-180 days) postoperative

Locations

12 sites in 6 countries. Site status is shown where the registry gives one.

  • Hanusch Krankenhaus

    Vienna, Austria

  • Gemini Eye Clinic

    Zlín, Czechia

  • Augen-Zentrum-Nordwest

    Ahaus, Germany

9 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.